• Enterosorption as a Method of Chronic Kidney Disease Treatment in Pregnant Women
en To content Full text of article

Enterosorption as a Method of Chronic Kidney Disease Treatment in Pregnant Women

PERINATOLOGY AND PEDIATRIC. UKRAINE. 2018.4(76):38-43; doi 10.15574/PP.2018.76.38

Limanskaya A. Yu., Tarnavska A. O., Davydova Iu. V.SI
«Institute of Pediatrics, Obstetrics and Gynecology named after Academician O.M. Lukyanova, National Academy of Medical Sciences of Ukraine», Kyiv

Aim: to investigate the efficacy of treatment for pregnant women with chronic II–III stage kidney disease due to glomerulonephritis.

Patients and methods. The study involved pregnant women who received treatment at 16–28 weeks of gestation during the first hospitalization to the unit. Women with chronic kidney disease were divided into two groups. The first group included 11 pregnant women who received traditional therapy (corticosteroids, potassium-retaining diuretics and cytostatics, if necessary, antihypertensives, antibiotics, drugs that improve renal microcirculation, etc.). The second group included 16 pregnant women who received traditional treatment along with maintenance therapy with the drug Atoxil, 1 vial (10 g of the formulation in the form of aqueous suspension) during the day in intervals between meals distributed evenly for 3 times. The duration of the sorbent course was 14–16 days.

Results and conclusions. The increase in the number of people with kidney disease accompanied by nitrogen metabolism disorders, as well as significant economic cost of treatment, leads to the search for additional available effective therapies. Among such methods is enteral enterosorption. Reducing endotoxin burden on organs and systems in combination with etiopathogenetic therapy can significantly improve condition of pregnant women, reduce manifestations of intoxication and improve the quality of life of women. Therefore, chronic kidney disease in the stage of azotemia is an indication for efferent therapy in the form of enteral enterosorption with the drug Atoxil (produced by Orisil-Pharm). Non-invasive nature of detoxification and proven efficacy make it possible to recommend Atoxil for the treatment of pregnant women.

Key words: pregnant, enterosorbtion, chronic kidney disease, Atoxil.


1. Podobed VM. (2013). Primenenie enterosorbtsii pri zabolevaniyah pochek, effektivnost Enterosgelya. Meditsinskie novosti. 12: 65—69.

2. Ahmad A, Samuelsen S. (2012). Hypertensive disorders in pregnancy and fetal death at different gestational lengths: a population study of 2 121 371 pregnancies. BJOG. 119; 12: 1521—1528. https://doi.org/10.1111/j.1471-0528.2012.03460.x; PMid:22925135

3. Bakker R, Steegers EA, Hofman A et al. (2011). Blood pressure in different gestational trimesters, fetal growth, and the risk of adverse birth outcomes: the generation R study. Am. J. Epidemiol. 174; 7: 797—806. https://doi.org/10.1093/aje/kwr151; PMid:21859836

4. Davison JM, Lindheimer MD. (1984). Chronic renal disease. Clin. Obstet. Gynecol. 27; 4: 891—901. https://doi.org/10.1097/00003081-198412000-00009; PMid:6151881

5. Ene-Iordache B, Perico N, Bikbov B, Carminati S et al. (2016). Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob. Health. 4; 5: e307-e119. https://doi.org/10.1016/S2214-109X(16)00071-1

6. Epstein FH. (2009). Pregnancy and renal disease. N Engl J Med. 8; 335: 277—278.

7. Levey A, Coresh J. (2011). Chronic kidney disease. Lancet. 14; 379: 165—168. https://doi.org/10.1053/j.ajkd.2011.06.007; https://doi.org/10.1053/j.ajkd.2011.02.171

8. Naghavi M, Wang H, Lozano R еt al. (2015). GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990—2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 385; 9963: 117—171.

9. Otero A, de Francisco A, Gayoso P, Garcia F; on behalf of the EPIRCE Study Group. (2010). Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrologia. 30(1): 78—86. PMid:20038967

10. Piccoli GB, Attini R, Vasario E et al. (2010). Pregnancy and chronic kidney disease: a challenge in all CKD stages. Clin. J. Am. Soc. Nephrol. 5; 5: 844—855. https://doi.org/10.2215/CJN.07911109; PMid:20413442 PMCid:PMC2863984

11. Piccoli GB, Fassio F, Attini R et al. (2012). Pregnancy in CKD: whom should we follow and why? Nephrol. Dial. Transplant. 27; 3: 111—118. https://doi.org/10.1093/ndt/gfs302

12. Williams D, Davison J. (2008). Chronic kidney disease in pregnancy. BMJ. 336; 7637: 211—215. https://doi.org/10.1136/bmj.39406.652986.BE; PMid:18219043 PMCid:PMC2213870

Article received: Sep 11, 2018. Accepted for publication: Dec 03, 2018.